Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice
- PMID: 1644913
- PMCID: PMC443115
- DOI: 10.1172/JCI115875
Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice
Abstract
Two immunotoxins were constructed by chemically coupling the monoclonal antibody C242 to Pseudomonas exotoxin A (PE) or a modified form, NlysPE40, that lacks the cell binding domain of PE. Monoclonal antibody C242 recognizes a specific sialylated carbohydrate epitope on a high molecular weight membrane glycoprotein present on cells of human colon, pancreatic, and cervical cancers. C242-PE and C242-NlysPE40 were very cytotoxic for cells expressing this antigen with 50% inhibition of protein synthesis occurring on Colo205 cells at 0.2 ng/ml (0.9 pM) for C242-PE and 6.0 ng/ml (31 pM) for C242-NlysPE40. The two immunotoxins also exhibited a strong antitumor effect on a human colon cancer xenograft grown in nude mice. The specificity and potency of these two C242 immunotoxins warrant their further development for the treatment of cancer.
Similar articles
-
Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3358-62. doi: 10.1073/pnas.88.8.3358. Proc Natl Acad Sci U S A. 1991. PMID: 2014255 Free PMC article.
-
Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.Int J Cancer. 1996 Jul 3;67(1):113-23. doi: 10.1002/(SICI)1097-0215(19960703)67:1<113::AID-IJC19>3.0.CO;2-F. Int J Cancer. 1996. PMID: 8690511
-
Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.Cancer Res. 1992 Oct 1;52(19):5379-85. Cancer Res. 1992. PMID: 1394141
-
Pseudomonas exotoxin--immunotoxins.Cancer Treat Res. 1988;37:161-73. doi: 10.1007/978-1-4613-1083-9_11. Cancer Treat Res. 1988. PMID: 2908624 Review.
-
Quantification of immunotoxin number for complete therapeutic response.Methods Mol Biol. 2001;166:111-23. doi: 10.1385/1-59259-114-0:111. Methods Mol Biol. 2001. PMID: 11217362 Review. No abstract available.
Cited by
-
Recombinant immunotoxins.Breast Cancer Res Treat. 1996;38(1):3-9. doi: 10.1007/BF01803778. Breast Cancer Res Treat. 1996. PMID: 8825117 Review.
-
Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies.Int J Mol Sci. 2013 Jul 12;14(7):14669-88. doi: 10.3390/ijms140714669. Int J Mol Sci. 2013. PMID: 23857061 Free PMC article.
-
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8618-23. doi: 10.1073/pnas.93.16.8618. Proc Natl Acad Sci U S A. 1996. PMID: 8710920 Free PMC article.
-
Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.Oncogene. 2008 Dec 11;27(58):7260-73. doi: 10.1038/onc.2008.328. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794797 Free PMC article.
-
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.Mol Cancer Res. 2020 Dec;18(12):1839-1848. doi: 10.1158/1541-7786.MCR-19-1037. Epub 2020 Sep 14. Mol Cancer Res. 2020. PMID: 32928910 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources